Global Bio-chem Technology Group Company Limited
GBCMF
$0.005
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.21% | 32.68% | 22.43% | 22.21% | 92.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.21% | 32.68% | 22.43% | 22.21% | 92.20% |
| Cost of Revenue | 23.30% | 23.74% | 18.86% | 18.64% | 58.41% |
| Gross Profit | 144.56% | 145.42% | 50.65% | 50.37% | 213.73% |
| SG&A Expenses | -21.33% | -21.06% | -15.65% | -15.80% | 12.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -69.28% | -69.18% | 55.93% | 56.01% | -56.03% |
| Total Operating Expenses | 11.45% | 11.85% | 20.45% | 20.23% | 32.58% |
| Operating Income | 106.46% | 106.48% | 475.32% | 474.18% | 52.00% |
| Income Before Tax | 1.74% | 1.40% | -75.86% | -75.91% | -162.37% |
| Income Tax Expenses | -- | -- | -108.66% | -108.28% | -- |
| Earnings from Continuing Operations | 1.74% | 1.40% | -75.30% | -75.34% | -431.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.74% | 1.40% | -78.27% | -78.31% | -143.71% |
| EBIT | 106.46% | 106.48% | 475.32% | 474.18% | 52.00% |
| EBITDA | 284.76% | 285.40% | -19.85% | -20.00% | 82.64% |
| EPS Basic | 0.00% | 0.00% | -78.25% | -78.57% | -120.00% |
| Normalized Basic EPS | 36.36% | 36.36% | 62.50% | 62.50% | 59.26% |
| EPS Diluted | 8.33% | 8.33% | -89.86% | -89.86% | -140.00% |
| Normalized Diluted EPS | 36.36% | 36.36% | 86.67% | 86.67% | 59.26% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.48% | 0.48% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 125.86% | 125.86% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |